Structure Database (LMSD)
LMSD: Structure-based search results
LM_ID | Common Name | Systematic Name | Formula | Mass | Main Class | Sub Class |
---|---|---|---|---|---|---|
LMFA03110050 | ent-8-D2c-IsoP | 8R,12R-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11S,15R] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110051 | 8-D2c-IsoP | 8S,12S-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11R,15S] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110052 | 8-epi-8-D2c-IsoP | 8R,12S-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11R,15S] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110053 | ent-8-epi-8-D2c-IsoP | 8S,12R-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11S,15R] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110054 | ent-8-epi-8-D2t-IsoP | 8S,12R-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11R,15S] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110055 | ent-8-D2t-IsoP | 8R,12R-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11R,15S] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110056 | 8-epi-8-D2t-IsoP | 8R,12S-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11S,15R] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110057 | 8-D2t-IsoP | 8S,12S-dihydroxy-14-oxo-5Z,9E- prostadienoic acid-cyclo[11S,15R] | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110221 | 11-epi-8-D2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110222 | 11-epi-8-D2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110223 | 8,11-diepi-8-D2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110224 | 8,11-diepi-8-D2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110225 | ent-11-epi-8-D2c-IsoP | (R,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110226 | ent-11-epi-8-D2t-IsoP | (R,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110227 | ent-8,11-diepi-8-D2c-IsoP | (S,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |
LMFA03110228 | ent-8,11-diepi-8-D2t-IsoP | (S,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5- hydroxy-3-oxo-2-pentylcyclopentyl)deca- 5,9-dienoic acid | C20H32O5 | 352.2250 | Eicosanoids [FA03] | Isoprostanes [FA0311] |